If you validated the drug target to cure a disease, but can’t hit it efficiently with high-throughput screening (HTS), fragment-based drug discovery could be…

One major challenge in drug discovery is determining whether a drug is behaving as intended, binding the “right” protein, inhibiting the correct target…

Assay Depot invited Dr. Heather Buschman to discuss protein microarrays and the future of biomarker discovery. Dr. Buschman earned her Ph.D. in Molecular…

What is the most successful preclinical strategy for drug discovery?  Finding the answer to this question is important if pharma is to keep…